These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 11000423)

  • 1. Alzheimer's disease: more than a 'cholinergic disorder' - evidence that cholinergic-monoaminergic interactions contribute to EEG slowing and dementia.
    Dringenberg HC
    Behav Brain Res; 2000 Nov; 115(2):235-49. PubMed ID: 11000423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin-dependent maintenance of spatial performance and electroencephalography activation after cholinergic blockade: effects of serotonergic receptor antagonists.
    Dringenberg HC; Zalan RM
    Brain Res; 1999 Aug; 837(1-2):242-53. PubMed ID: 10434009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].
    Šaponjić J
    Glas Srp Akad Nauka Med; 2011; (51):85-97. PubMed ID: 22165729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of tacrine on EEG slowing in the rat: enhancement by concurrent monoamine therapy.
    Dringenberg HC; Diavolitsis P; Noseworthy PA
    Neurobiol Aging; 2000; 21(1):135-43. PubMed ID: 10794858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The EEG as an indicator of cholinergic deficit in Alzheimer's disease].
    Adler G
    Fortschr Neurol Psychiatr; 2000 Aug; 68(8):352-6. PubMed ID: 11006862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropharmacology of cognition and memory: a unifying theory of neuromodulator imbalance in psychiatry and amnesia.
    Vakalopoulos C
    Med Hypotheses; 2006; 66(2):394-431. PubMed ID: 16300905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dementia: animal models of the cognitive impairments following damage to the basal forebrain cholinergic system.
    Olton DS
    Brain Res Bull; 1990 Sep; 25(3):499-502. PubMed ID: 2292047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive enhancers in theory and practice: studies of the cholinergic hypothesis of cognitive deficits in Alzheimer's disease.
    Robbins TW; McAlonan G; Muir JL; Everitt BJ
    Behav Brain Res; 1997 Feb; 83(1-2):15-23. PubMed ID: 9062655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 12th J. A. F. Stevenson memorial lecture. Aging, Alzheimer's disease, and the cholinergic system.
    McGeer PL
    Can J Physiol Pharmacol; 1984 Jul; 62(7):741-54. PubMed ID: 6149804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormalities of neural circuitry in Alzheimer's disease: hippocampus and cortical cholinergic innervation.
    Geula C
    Neurology; 1998 Jul; 51(1 Suppl 1):S18-29; discussion S65-7. PubMed ID: 9674759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation by DSP-4 of EEG slowing and memory impairment in basal forebrain-lesioned rats.
    Abe K; Horiuchi M; Yoshimura K
    Eur J Pharmacol; 1997 Feb; 321(2):149-55. PubMed ID: 9063682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease.
    Garcia-Alloza M; Gil-Bea FJ; Diez-Ariza M; Chen CP; Francis PT; Lasheras B; Ramirez MJ
    Neuropsychologia; 2005; 43(3):442-9. PubMed ID: 15707619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased effectiveness of tacrine by deprenyl co-treatment in rats: EEG and behavioral evidence.
    Dringenberg HC; Laporte PP; Diavolitsis P
    Neuroreport; 2000 Nov; 11(16):3513-6. PubMed ID: 11095509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholinergic strategies for Alzheimer's disease.
    Winkler J; Thal LJ; Gage FH; Fisher LJ
    J Mol Med (Berl); 1998 Jul; 76(8):555-67. PubMed ID: 9694432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholinergic central system, Alzheimer's disease, and anesthetics liaison: a vicious circle?
    Schifilliti D; Santamaria LB; Rosa G; Di Nino G; Mandal PK; Fodale V
    J Alzheimers Dis; 2010; 22 Suppl 3():35-41. PubMed ID: 20858949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive deficits in olivopontocerebellar atrophy: implications for the cholinergic hypothesis of Alzheimer's dementia.
    Kish SJ; el-Awar M; Schut L; Leach L; Oscar-Berman M; Freedman M
    Ann Neurol; 1988 Aug; 24(2):200-6. PubMed ID: 3178175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cholinergic system in aging and neuronal degeneration.
    Schliebs R; Arendt T
    Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen and basal forebrain cholinergic neurons: implications for brain aging and Alzheimer's disease-related cognitive decline.
    Gibbs RB; Aggarwal P
    Horm Behav; 1998 Oct; 34(2):98-111. PubMed ID: 9799621
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.